(MedPage Today) — CHICAGO — An investigational viral immunotherapy (CAN-2409; aglatimagene besadenovec) combined with a prodrug improved disease-free survival (DFS) when added to standard curative-intent radiotherapy for newly diagnosed localized…
Source link : https://www.medpagetoday.com/meetingcoverage/asco/115909
Author :
Publish date : 2025-06-04 19:50:00
Copyright for syndicated content belongs to the linked Source.
